Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 3/2012

01.03.2012 | Maternal-Fetal Medicine

The quadruple test for Down syndrome screening in pregnant women of advanced maternal age

verfasst von: Ji Young Kwon, In Yang Park, Seong-min Kwon, Chan Joo Kim, Jong Chul Shin

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the current study was to determine whether or not the quadruple test for screening Down syndrome is an effective method to replace direct amniocentesis in pregnant women ≥35 years of age.

Methods

This study analyzed the screening performance of the quadruple test according to maternal age at delivery among subjects who had a quadruple screening test at 1 of 4 hospitals during a 5-year period and for whom data on fetal chromosomal abnormalities were available.

Results

The study population of 9,435 pregnant women was divided into 3 groups according to maternal age: 6,922 women were <35 years of age; 2,284 were 35–39 years of age; and 229 women ≥40 years of age. The detection and false-positive rates of the quadruple screening test for Down or Edward syndrome in the 3 groups of women were 80 and 6.6%, 200 and 15.8%, and 100 and 35.3%, respectively.

Conclusions

Under conditions in which first trimester screening test is not available, the quadruple screening test is a better choice than direct amniocentesis for pregnancies complicated by advanced maternal age. When providing genetic counseling, we need to explain the accurate detection and false-positive rates of the screening test according to maternal age.
Literatur
1.
Zurück zum Zitat American College of Obstetricians and Gynecologists (ACOG) (1976) Antenatal diagnosis of genetic disorders. ACOG Technical Bulletin #39 American College of Obstetricians and Gynecologists (ACOG) (1976) Antenatal diagnosis of genetic disorders. ACOG Technical Bulletin #39
2.
Zurück zum Zitat The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group (1998) Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 351:242–247CrossRef The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group (1998) Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 351:242–247CrossRef
3.
Zurück zum Zitat Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Porter TF, Luthy DA, Comstock CH, Saade GR, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D’Alton ME (2006) Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 108:1067–1072PubMedCrossRef Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Porter TF, Luthy DA, Comstock CH, Saade GR, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D’Alton ME (2006) Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 108:1067–1072PubMedCrossRef
4.
Zurück zum Zitat Benn PA, Egan JF, Fang M, Smith-Bindman R (2004) Changes in the utilization of prenatal diagnosis. Obstet Gynecol 103:1255–1260PubMedCrossRef Benn PA, Egan JF, Fang M, Smith-Bindman R (2004) Changes in the utilization of prenatal diagnosis. Obstet Gynecol 103:1255–1260PubMedCrossRef
5.
Zurück zum Zitat ACOG Committee on Practice Bulletins (2007) ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 109:217–227CrossRef ACOG Committee on Practice Bulletins (2007) ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 109:217–227CrossRef
6.
Zurück zum Zitat Driscoll DA, Morgan MA, Schulkin J (2009) Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 200(459):e1–e9PubMed Driscoll DA, Morgan MA, Schulkin J (2009) Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 200(459):e1–e9PubMed
7.
Zurück zum Zitat Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D’Alton ME, First- and second-trimester evaluation of risk (FASTER) research consortium (2005) First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 353:2001–2011PubMedCrossRef Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D’Alton ME, First- and second-trimester evaluation of risk (FASTER) research consortium (2005) First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 353:2001–2011PubMedCrossRef
8.
Zurück zum Zitat Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM (2003) First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10:56–104 (published erratum appears in J Med Screen. 2006;13(1):51–52)PubMedCrossRef Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM (2003) First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10:56–104 (published erratum appears in J Med Screen. 2006;13(1):51–52)PubMedCrossRef
9.
Zurück zum Zitat Reynolds TM, Nix AB, Dunstan FD, Dawson AJ (1993) Age-specific detection and false-positive rates: an aid to counseling in Down syndrome risk screening. Obstet Gynecol 81:447–450PubMed Reynolds TM, Nix AB, Dunstan FD, Dawson AJ (1993) Age-specific detection and false-positive rates: an aid to counseling in Down syndrome risk screening. Obstet Gynecol 81:447–450PubMed
10.
Zurück zum Zitat Spencer K (2001) Age related detection and false positive rates when screening for Down’s syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A. BJOG 108:1043–1046PubMedCrossRef Spencer K (2001) Age related detection and false positive rates when screening for Down’s syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A. BJOG 108:1043–1046PubMedCrossRef
11.
Zurück zum Zitat Sadler M (1997) Serum screening for Down’s syndrome: how much do health professionals know? Br J Obstet Gynaecol 104:176–179PubMedCrossRef Sadler M (1997) Serum screening for Down’s syndrome: how much do health professionals know? Br J Obstet Gynaecol 104:176–179PubMedCrossRef
12.
Zurück zum Zitat Cleary-Goldman J, Morgan MA, Malone FD, Robinson JN, D’Alton ME, Schulkin J (2006) Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 107:11–17PubMedCrossRef Cleary-Goldman J, Morgan MA, Malone FD, Robinson JN, D’Alton ME, Schulkin J (2006) Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 107:11–17PubMedCrossRef
13.
Zurück zum Zitat Nakata N, Wang Y, Bhatt S (2010) Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn 30:198–206PubMed Nakata N, Wang Y, Bhatt S (2010) Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn 30:198–206PubMed
14.
Zurück zum Zitat Schreinemachers DM, Cross PK, Hook EB (1982) Rates of trisomies 21, 18, 13 and other chromosome abnormalities in about 20,000 prenatal studies compared with estimated rates in live births. Hum Genet 61:318–324PubMedCrossRef Schreinemachers DM, Cross PK, Hook EB (1982) Rates of trisomies 21, 18, 13 and other chromosome abnormalities in about 20,000 prenatal studies compared with estimated rates in live births. Hum Genet 61:318–324PubMedCrossRef
15.
Zurück zum Zitat Hook EB, Cross PK, Jackson L, Pergament E, Brambati B (1988) Maternal age-specific rates of 47, +21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis. Am J Hum Genet 42:797–807PubMed Hook EB, Cross PK, Jackson L, Pergament E, Brambati B (1988) Maternal age-specific rates of 47, +21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis. Am J Hum Genet 42:797–807PubMed
16.
Zurück zum Zitat Forabosco A, Percesepe A, Santucci S (2009) Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses. Eur J Hum Genet 17:897–903PubMedCrossRef Forabosco A, Percesepe A, Santucci S (2009) Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses. Eur J Hum Genet 17:897–903PubMedCrossRef
17.
Zurück zum Zitat Boyd PA, Loane M, Garne E, Khoshnood B, Dolk H, EUROCAT working group (2011) Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet 19:231–234PubMedCrossRef Boyd PA, Loane M, Garne E, Khoshnood B, Dolk H, EUROCAT working group (2011) Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet 19:231–234PubMedCrossRef
18.
Zurück zum Zitat Forrester MB, Merz RD (1999) Trisomies 13 and 18: prenatal diagnosis and epidemiologic studies in Hawaii, 1986–1997. Genet Test 3:335–340PubMedCrossRef Forrester MB, Merz RD (1999) Trisomies 13 and 18: prenatal diagnosis and epidemiologic studies in Hawaii, 1986–1997. Genet Test 3:335–340PubMedCrossRef
Metadaten
Titel
The quadruple test for Down syndrome screening in pregnant women of advanced maternal age
verfasst von
Ji Young Kwon
In Yang Park
Seong-min Kwon
Chan Joo Kim
Jong Chul Shin
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 3/2012
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2052-1

Weitere Artikel der Ausgabe 3/2012

Archives of Gynecology and Obstetrics 3/2012 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.